BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 12900514)

  • 1. Expression of membrane-bound HLA-G at the maternal-fetal interface is not associated with pregnancy maintenance among patients with idiopathic recurrent pregnancy loss.
    Patel RN; Quack KC; Hill JA; Schust DJ
    Mol Hum Reprod; 2003 Sep; 9(9):551-7. PubMed ID: 12900514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defect in lipid rafts results in failed tolerance induction at the maternal-fetal interface: a possible cause for the recurrent spontaneous abortion.
    Chen LJ; Zhou H; Zou L
    Med Hypotheses; 2008 Aug; 71(2):275-8. PubMed ID: 18417296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-G genotypes and pregnancy outcome in couples with unexplained recurrent miscarriage.
    Aldrich CL; Stephenson MD; Karrison T; Odem RR; Branch DW; Scott JR; Schreiber JR; Ober C
    Mol Hum Reprod; 2001 Dec; 7(12):1167-72. PubMed ID: 11719594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble human leukocyte antigen-G isoforms in maternal plasma in early and late pregnancy.
    Rizzo R; Andersen AS; Lassen MR; Sørensen HC; Bergholt T; Larsen MH; Melchiorri L; Stignani M; Baricordi OR; Hviid TV
    Am J Reprod Immunol; 2009 Nov; 62(5):320-38. PubMed ID: 19811467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble HLA-G blood levels are not increased during ongoing pregnancy in women with a history of recurrent pregnancy loss.
    Krop J; Van Der Keur C; Kapsenberg JM; Den Hollander F; Van Der Hoorn MLP; Heidt S; Claas FHJ; Eikmans M
    J Reprod Immunol; 2022 Sep; 153():103665. PubMed ID: 35905658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [HLA-G: from feto-maternal tolerance to organ grafting].
    Carosella ED
    Bull Mem Acad R Med Belg; 2009; 164(3-4):87-99; discussion 99-101. PubMed ID: 20120086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential role of HLA-G polymorphism in maternal tolerance to the developing fetus.
    Agrawal S; Pandey MK
    J Hematother Stem Cell Res; 2003 Dec; 12(6):749-56. PubMed ID: 14977483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune modulation of HLA-G dimer in maternal-fetal interface.
    Kuroki K; Maenaka K
    Eur J Immunol; 2007 Jul; 37(7):1727-9. PubMed ID: 17587197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of genetic variants in the 3'UTR of HLA-G with Recurrent Pregnancy Loss.
    Amodio G; Canti V; Maggio L; Rosa S; Castiglioni MT; Rovere-Querini P; Gregori S
    Hum Immunol; 2016 Oct; 77(10):886-891. PubMed ID: 27370685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-G molecules: from maternal-fetal tolerance to tissue acceptance.
    Carosella ED; Moreau P; Le Maoult J; Le Discorde M; Dausset J; Rouas-Freiss N
    Adv Immunol; 2003; 81():199-252. PubMed ID: 14711057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis.
    Rouas-Freiss N; Gonçalves RM; Menier C; Dausset J; Carosella ED
    Proc Natl Acad Sci U S A; 1997 Oct; 94(21):11520-5. PubMed ID: 9326642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Materno-fetal immunobiology in normal pregnancy and its possible failure in recurrent spontaneous abortion?
    Vince GS; Johnson PM
    Hum Reprod; 1995 Dec; 10 Suppl 2():107-13. PubMed ID: 8745308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of HLA-G in maternal-fetal immune tolerance.
    Rouas-Freiss N; Khalil-Daher I; Marchal-Bras Goncalves R; Menier C; Dausset J; Carosella ED
    Transplant Proc; 1999; 31(1-2):724-5. PubMed ID: 10083309
    [No Abstract]   [Full Text] [Related]  

  • 14. Human leucocyte antigen class Ib molecules in pregnancy success and early pregnancy loss.
    Dahl M; Hviid TV
    Hum Reprod Update; 2012; 18(1):92-109. PubMed ID: 22114131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viewpoint on the functionality of the human leukocyte antigen-G null allele at the fetal-maternal interface.
    Moreau P; Dausset J; Carosella ED; Rouas-Freiss N
    Biol Reprod; 2002 Nov; 67(5):1375-8. PubMed ID: 12390865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-G polymorphisms and soluble HLA-G protein levels in women with recurrent pregnancy loss from Basrah province in Iraq.
    Jassem RM; Shani WS; Loisel DA; Sharief M; Billstrand C; Ober C
    Hum Immunol; 2012 Aug; 73(8):811-7. PubMed ID: 22651916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-G and pregnancy adverse outcomes.
    Cecati M; Giannubilo SR; Emanuelli M; Tranquilli AL; Saccucci F
    Med Hypotheses; 2011 Jun; 76(6):782-4. PubMed ID: 21376476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal blocking antibodies, the fetal allograft, and recurrent abortion.
    Lancet; 1983 Nov; 2(8360):1175-6. PubMed ID: 6139531
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of Human Leukocyte Antigens at the Feto-Maternal Interface in Normal and Pathological Pregnancy: An Update.
    Tersigni C; Meli F; Neri C; Iacoangeli A; Franco R; Lanzone A; Scambia G; Di Simone N
    Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32635423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The expression of human leukocyte antigen G and E on human first trimester placenta and its relationship with recurrent spontaneous abortion].
    Peng B; Zhang L; Xing AY; Hu M; Liu SY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Nov; 39(6):976-9. PubMed ID: 19253840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.